Skip to main content
An official website of the United States government

Funded Grants

PI Name Sort descending PI Organization Title Grant Number Initiative Program Official
Badve, Sunil S.

Emory University
United States

Early prediction of lethal phenotypes in triple negative breast cancer using multiscale, multi-modality platforms 5R01CA281932-02 Wendy Wang, Ph.D., M.Sc.
Bae-Jump, Victoria Lin

Univ Of North Carolina Chapel Hill
United States

Obesity-driven Metabolic and Molecular Biomarkers of Metformin Response in Endometrial Cancer 5R37CA226969-07 Goli Samimi, Ph.D., M.P.H.
Baghdadi, Tareq Al

Saint Joseph Mercy Health System
United States

Michigan Cancer Research Consortium NCORP 3UG1CA189971-11S1 Vanessa A. White, M.P.H.
Balskus, Emily Patricia

Harvard University
United States

PROSPECT: Pathways, Risk factors, and mOleculeS to Prevent Early-onset Colorectal Tumors 1OT2CA297577-01 Asad Umar, D.V.M., Ph.D.
Balu, Mihaela

University Of California-Irvine
United States

Fast, large area, multiphoton exoscope (FLAME) for improving early detection of melanoma 5R01CA259019-03 PAR-20-155 (R01 Clinical Trial Optional) Richard Mazurchuk, Ph.D.
Banerjee, Imon

Mayo Clinic Arizona
United States

Multimodal AI Fusion Model for Early Detection for Pancreatic Cancer 1R01CA289249-01 Nick Hodges, Ph.D.
Bao, Ting

Dana-Farber Cancer Inst
United States

Yoga for Chemotherapy-induced Peripheral Neuropathy Treatment (YCT) Trial 5R01CA251470-06 Goli Samimi, Ph.D., M.P.H.
Bao, Ting

Dana-Farber Cancer Inst
United States

Acupuncture for Chemothrapy-induced Peripheral Neuropathy Treatment (ACT) Trial 5R37CA248563-05 Asad Umar, D.V.M., Ph.D.
Barber, Glen N.

University Of Miami School Of Medicine
United States

Development of A HTLV-1 Vaccine 5R01CA252049-04 PA-20-185 (Parent R01 Clinical Trial Not Allowed) Marjorie Perloff, M.D.
Barroilhet, Lisa M

University Of Wisconsin-Madison
United States

Repurposing Atovaquone for Preventing Ovarian Cancer: An Example of Successful Inhibition of Oxidative Phosphorylation 5R01CA238423-05 Goli Samimi, Ph.D., M.P.H.